{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:15:36Z","timestamp":1778314536115,"version":"3.51.4"},"reference-count":61,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T00:00:00Z","timestamp":1617408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Otol Rhinol Laryngol"],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Intranasal sprays (INSs) are commonly used medications for the treatment of many rhinologic conditions. Despite their popularity, an analysis of a nationwide reporting database and comparison to the available literature has never been performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The Food and Drug Administration Adverse Event Reporting System (FAERS) database was accessed to obtain adverse event (AE) records from 2014 to 2019 for varying INSs, including: 10 corticosteroids, 1 alpha adrenergic, and 3 antihistamines. The Proportional Reporting Ratios (PRR) and Reporting Odds Ratios (ROR) were calculated for dyspnea, anosmia, ageusia\/dysgeusia, epistaxis, and headache. A PRR\u2009\u2265\u20092 or ROR\u2009\u2265\u20091 was considered significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Corticosteroids had 98\u2009864 total reported AEs to the database, followed by antihistamines (7011) and alpha adrenergics (2071). In total, dyspnea was reported 5843 times, followed by headache (4230), epistaxis (1205), ageusia\/dysgeusia (920), and anosmia (312). Overall, PRR and ROR values for dyspnea ranged from 0.51 to 4.25 and 0.51 to 4.49; for dysgeusia\/ageusia from 0.56 to 6.09 and 0.56 to 6.12; and for epistaxis from 1.03 to 27.24 and 1.03 to 30.76, respectively. All medications which listed anosmia within the top AEs had PRR and ROR values exceeding 2 and 1, respectively. The PRR for headache exceeded 2 for 1 medication and the ROR exceeded 1 in 7 medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The AEs of dyspnea, anosmia, ageusia\/dysgeusia, epistaxis, and headache are reported within the FAERS database for commonly prescribed INSs. When compared against the existing scientific literature, the clinical significance of this reporting tool from the FDA for these classes of medications remains unvalidated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/00034894211007222","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T03:12:43Z","timestamp":1617419563000},"page":"1292-1301","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Adverse Events Associated with Intranasal Sprays: An Analysis of the Food and Drug Administration Database and Literature Review"],"prefix":"10.1177","volume":"130","author":[{"given":"Salma","family":"Ahsanuddin","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5773-182X","authenticated-orcid":false,"given":"Roman","family":"Povolotskiy","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahma","family":"Tayyab","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-2485","authenticated-orcid":false,"given":"Wissam","family":"Nasser","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-0268","authenticated-orcid":false,"given":"Gregory L.","family":"Barinsky","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8877-5964","authenticated-orcid":false,"given":"Jordon G.","family":"Grube","sequence":"additional","affiliation":[{"name":"Department of Surgery, Division of Otolaryngology\/Head and Neck Surgery, Albany Medical Center, Albany, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Paskhover","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA"},{"name":"Department of Facial Plastics and Reconstructive Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,4,3]]},"reference":[{"key":"bibr1-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(02)02529-1"},{"key":"bibr2-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2003.10.001"},{"key":"bibr3-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-017-0720-3"},{"key":"bibr4-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1975.tb01848.x"},{"key":"bibr5-00034894211007222","unstructured":"ClinCalc.com. Flutcasone drug usage statistics, United States, 2006-2016. Published 2017. Updated January 18 2021. Accessed November 27, 2019. https:\/\/clincalc.com\/DrugStats\/Drugs\/Fluticasone"},{"key":"bibr6-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)63030-X"},{"key":"bibr7-00034894211007222","doi-asserted-by":"publisher","DOI":"10.2500\/ajra.2013.27.3949"},{"key":"bibr8-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0665-5"},{"key":"bibr9-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1177\/0194599820931455"},{"key":"bibr10-00034894211007222","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200326120-00003"},{"key":"bibr11-00034894211007222","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.5892"},{"key":"bibr12-00034894211007222","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.10453"},{"key":"bibr13-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0116-9"},{"key":"bibr14-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2924"},{"key":"bibr15-00034894211007222","unstructured":"American Academy of Allergy Asthma & Immunology. Allergy & asthma medication guide. Updated March 2020. Accessed June 13, 2019. https:\/\/www.aaaai.org\/conditions-and-treatments\/drug-guide\/nasal-medication"},{"key":"bibr16-00034894211007222","unstructured":"Administration USFD. Questions and answers on FDA\u2019s Adverse Event Reporting System (FAERS). Published June 14, 2018. Accessed November 27, 2019. https:\/\/www.fda.gov\/drugs\/surveillance\/questions-and-answers-fdas-adverse-event-reporting-system-faers"},{"key":"bibr17-00034894211007222","unstructured":"TLIBRXZ K-h. Open FDA: Proportional Reporting Ratio (PRR) for a drug. Published 2015. Accessed January 3, 2020. https:\/\/openfda.shinyapps.io\/RR_D\/"},{"key":"bibr18-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_232.x"},{"key":"bibr19-00034894211007222","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629100-00005"},{"key":"bibr20-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1002\/pds.677"},{"key":"bibr21-00034894211007222","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.6048"},{"key":"bibr22-00034894211007222","unstructured":"B\u00f6hm R. Primer on disproportionality analysis. Published 2018. Accessed June 30, 2019. http:\/\/openvigil.sourceforge.net\/doc\/DPA.pdf"},{"key":"bibr23-00034894211007222","unstructured":"European Medicines Agency Eudravigilance Expert Working Group.EMAEEWG (EV-EWG). Guideline on the use of statistical signal detection methods in the eudravigilance data analysis system. Evaluation of medicines for human use. Published June 2008. Accessed June 30, 2019. https:\/\/app.gxp-services.net\/guidemgr\/files\/WC500011434.pdf"},{"key":"bibr24-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050466"},{"key":"bibr25-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1992.tb03085.x"},{"issue":"6","key":"bibr26-00034894211007222","volume":"13","author":"Johnson DA","year":"1993","journal-title":"Pharmacotherapy"},{"key":"bibr27-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1993.tb01955.x"},{"key":"bibr28-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.093278"},{"key":"bibr29-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-199605000-00016"},{"key":"bibr30-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1177\/106002809102501007"},{"key":"bibr31-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/0952-8180(95)00060-U"},{"key":"bibr32-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000628"},{"key":"bibr33-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/j.vascn.2015.05.011"},{"key":"bibr34-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007647"},{"key":"bibr35-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e31817c1368"},{"key":"bibr36-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1987.01860050093023"},{"key":"bibr37-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200102000-00002"},{"key":"bibr38-00034894211007222","unstructured":"Drugs.com. What\u2019s the difference between Xhance and Flonase allergy relief? Published 2018. Accessed June 15, 2020. https:\/\/www.drugs.com\/medical-answers\/difference-between-xhance-flonase-allergy-relief-3342537\/"},{"issue":"1","key":"bibr39-00034894211007222","first-page":"30","volume":"34","author":"Thongngarm T","year":"2016","journal-title":"Asian Pac J Allergy Immunol"},{"key":"bibr40-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050507"},{"key":"bibr41-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.01.077"},{"key":"bibr42-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)61954-0"},{"key":"bibr43-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.08.044"},{"issue":"1","key":"bibr44-00034894211007222","first-page":"1","volume":"22","author":"Sastre J","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"bibr45-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1258\/002221503322542818"},{"key":"bibr46-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1177\/0194599819832277"},{"key":"bibr47-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1177\/000348949510400906"},{"issue":"8","key":"bibr48-00034894211007222","first-page":"210","volume":"58","author":"Doo G","year":"1999","journal-title":"Hawaii Med J"},{"key":"bibr49-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(05)70086-9"},{"key":"bibr50-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(93)90058-N"},{"key":"bibr51-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.24.3097"},{"key":"bibr52-00034894211007222","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730040-00004"},{"key":"bibr53-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-002-0543-1"},{"key":"bibr54-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.2.e23"},{"key":"bibr55-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(96)70119-7"},{"key":"bibr56-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/0149-2918(95)80040-9"},{"key":"bibr57-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)60663-1"},{"key":"bibr58-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1159\/000055714"},{"issue":"10","key":"bibr59-00034894211007222","volume":"10","author":"Deckx L","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr60-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1002\/art.21292"},{"key":"bibr61-00034894211007222","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.1040631"}],"container-title":["Annals of Otology, Rhinology &amp; Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00034894211007222","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/00034894211007222","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/00034894211007222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:34:29Z","timestamp":1777376069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/00034894211007222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,3]]},"references-count":61,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["10.1177\/00034894211007222"],"URL":"https:\/\/doi.org\/10.1177\/00034894211007222","relation":{},"ISSN":["0003-4894","1943-572X"],"issn-type":[{"value":"0003-4894","type":"print"},{"value":"1943-572X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,3]]}}}